Home / Resource Library / Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell LymphomaReal World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma ASH 2024